Posts Tagged ‘Keytruda’
Personalized mRNA treatment reduces melanoma recurrence in landmark Phase 3 trial
Inova Schar Cancer was among the trial’s leading-enrolling sites, with participation led by principal investigator Dr. Sekwon Jang. A personalized mRNA-based treatment reduced the risk of melanoma returning or causing death by 42% when added to the immunotherapy Keytruda, according to Phase 3 results presented at the 2026 European Society for Medical Oncology Congress. The…
Read More